Canatu receives further reactor order from FST for pellicle manufacturing
Canatu says it receives a further reactor order from FST, describing it as validation of its CNT technology for pellicle manufacturing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.